Últimos Artículos de Endocrine Related Cancer
- ERRATUM: Roles of the HOXA10 gene during castrate-resistant prostate cancer progression
- In vivo and in vitro analysis of functional effects of the SDHD H50R variant
- FT3 and FT3/FT4 ratio are decreased and not compensated by levothyroxine treatment in TKI-treated thyroid cancer patients
- Clinicopathological characteristics associated with the prognosis of recurrent gonadotroph tumors
- Biology of RET receptor and its ligands: focus on the nervous system
- Why do we continue to have an incomplete understanding of estrogen receptor(s) actions in cancer systems?
- Surrogate molecular classification of LAR breast cancer in routine workflow
- Chemokines with CXC motif and their receptors in neuroendocrine neoplasms
- Genotype-specific neoplastic risk profiles in patients with VHL disease
- Spanish consensus on the diagnosis and management of adrenocortical carcinoma
- From bench to bedside in the sella: translational developments in pituitary tumour genetics
- Sexual dimorphism in thyroid cancer: evidence from preclinical studies
- The genetic changes in 11p15.5-related pheochromocytomas and paragangliomas
- Genomic testing for RET in the clinic: UK and global perspective
- Exploring the tumor suppressor role of RIN1 in familial thyroid carcinoma
- Management of patients with small pancreatic neuroendocrine tumors from a biomarker and surgical perspective
- Evaluation of prognostic factors in advanced pediatric ACC
- Inflammation-based score in pediatric adrenocortical carcinoma
- Limited value of genetic profiling in guiding radioiodine therapy for metastatic differentiated thyroid cancer
- ob/ob obese mice promote tumorigenesis of endometrial cancer associated with Pten deficiency